For the latest edition of our Nutrition Asia video series, we spoke with ingredient giant DSM's VP for human nutrition and health in APAC, Andre Rhoen, and Alina Uchida, the director of product development at the rapidly-growing personalised nutrition brand Imagene Labs.
In the video, we ask them to gauge how consumer understanding of the health benefits of personalised nutrition is progressing in the region, and to assess if has the potential to shift from being a premium product to something with mass appeal.
They also share their views on how governments can help boost the nutritional status of their populations and fight issues such as diabetes by partnering with industry to develop personalised nutrition solutions.
Finally, they debate how effective partnerships between MNCs and start-ups can help the sector thrive, before highlighting some emerging personalised nutrition business opportunities.
Earlier this month, we revealed how DSM Japan is to begin working with with DeNA Life Science as it seeks to expand its activity in the personalised nutrition space.
DeNA Life Science's strengths lie in digital services development and operations, including the genetic testing service MYCODE. DSM believes that aligning this with its food and nutrition know-how can lead to more tailored and personal health solutions.
Meanwhile, Singapore firm Imagene Labs has rapidly expanded across the region over the past two years with its personalised nutrition and skincare products.
On the B2B side, the company distributes products via wellness centres, gyms and fitness facilities, beauty and spa operations, aesthetic centres, private hospitals, and insurance firms. In the B2C aspect, individual consumers are able to access Imagene Labs' genetic testing products and services on its website.
In the past 12 months, the firm has launched in Malaysia, Hong Kong, China, Thailand and Australia.
Watch the video to find out more.